Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1962 1
1985 1
1986 3
1987 4
1989 2
1990 3
1991 1
1992 3
1993 7
1994 8
1995 1
1996 10
1997 13
1998 28
1999 19
2000 16
2001 17
2002 30
2003 27
2004 40
2005 46
2006 46
2007 69
2008 90
2009 118
2010 129
2011 171
2012 207
2013 250
2014 270
2015 303
2016 313
2017 284
2018 392
2019 486
2020 522
2021 617
2022 751
2023 771
2024 830
2025 241

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

6,351 results

Results by year

Filters applied: . Clear all
Page 1
Hyperacute rejection-engineered oncolytic virus for interventional clinical trial in refractory cancer patients.
Zhong L, Gan L, Wang B, Wu T, Yao F, Gong W, Peng H, Deng Z, Xiao G, Liu X, Na J, Xia D, Yu X, Zhang Z, Xiang B, Huo Y, Yan D, Dong Z, Fang F, Ma Y, Jin G, Su D, Liu X, Li Q, Liao H, Tang C, He J, Tang Z, Zhang S, Qiu B, Yang Z, Yang L, Chen Z, Zeng M, Feng R, Jiao J, Liao Y, Wang T, Wu L, Mi Z, Liu Z, Shi S, Zhang K, Shi W, Zhao Y. Zhong L, et al. Cell. 2025 Feb 20;188(4):1119-1136.e23. doi: 10.1016/j.cell.2024.12.010. Epub 2025 Jan 17. Cell. 2025. PMID: 39826543 Free article. Clinical Trial.
A gB nanoparticle vaccine elicits a protective neutralizing antibody response against EBV.
Sun C, Kang YF, Fang XY, Liu YN, Bu GL, Wang AJ, Li Y, Zhu QY, Zhang H, Xie C, Kong XW, Peng YJ, Lin WJ, Zhou L, Chen XC, Lu ZZ, Xu HQ, Hong DC, Zhang X, Zhong L, Feng GK, Zeng YX, Xu M, Zhong Q, Liu Z, Zeng MS. Sun C, et al. Among authors: zhong l. Cell Host Microbe. 2023 Nov 8;31(11):1882-1897.e10. doi: 10.1016/j.chom.2023.09.011. Epub 2023 Oct 16. Cell Host Microbe. 2023. PMID: 37848029 Free article.
In Reply.
Rubin A, Zhong L, Nacke L, Woolfolk C, Raghuraman N, Carter EB, Kelly J. Rubin A, et al. Among authors: zhong l. Obstet Gynecol. 2023 Mar 1;141(3):620-621. doi: 10.1097/AOG.0000000000005089. Obstet Gynecol. 2023. PMID: 36800854 No abstract available.
Management of chronic pain secondary to temporomandibular disorders: a systematic review and network meta-analysis of randomised trials.
Yao L, Sadeghirad B, Li M, Li J, Wang Q, Crandon HN, Martin G, Morgan R, Florez ID, Hunskaar BS, Wells J, Moradi S, Zhu Y, Ahmed MM, Gao Y, Cao L, Yang K, Tian J, Li J, Zhong L, Couban RJ, Guyatt GH, Agoritsas T, Busse JW. Yao L, et al. Among authors: zhong l. BMJ. 2023 Dec 15;383:e076226. doi: 10.1136/bmj-2023-076226. BMJ. 2023. PMID: 38101924
Adrenomedullin has a pivotal role in trophoblast differentiation: A promising nanotechnology-based therapeutic target for early-onset preeclampsia.
Zhang Q, Lee CL, Yang T, Li J, Zeng Q, Liu X, Liu Z, Ruan D, Li Z, Kan ASY, Cheung KW, Mak ASL, Ng VWY, Zhao H, Fan X, Duan YG, Zhong L, Chen M, Du M, Li RHW, Liu P, Ng EHY, Yeung WSB, Gao Y, Yao Y, Chiu PCN. Zhang Q, et al. Among authors: zhong l. Sci Adv. 2023 Nov 3;9(44):eadi4777. doi: 10.1126/sciadv.adi4777. Epub 2023 Nov 3. Sci Adv. 2023. PMID: 37922358 Free PMC article.
6,351 results